Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.
Marla Scott, MD
Advertisement
Articles by Marla Scott, MD
Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.
Advertisement
Latest Updated Articles
PARP inhibitors: Choosing what to use in epithelial ovarian cancerPublished: June 23rd 2020 | Updated:
PARP inhibitors: Choosing what to use in epithelial ovarian cancerPublished: April 7th 2020 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Ayesha Dholakia, MD, discusses firearms as leading cause of US maternal death
2
Sex toy use linked to orgasm frequency in women over 60
3
Paracetamol use in pregnancy not clearly linked to autism or ADHD
4
Major gaps found in endometriosis policies worldwide
5
